- Home
- OPT
OPT
Opthea Limited
as 12-18-2024 1:41pm EST
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
| Founded: | 1984 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 767.9M | IPO Year: | 2020 |
| Target Price: | $12.00 | AVG Volume (30 days): | 13.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.79 - $5.45 | Next Earning Date: | 08-30-2024 |
| Revenue: | $261,859 | Revenue Growth: | -32.03% |
| Revenue Growth (this year): | -32.5% | Revenue Growth (next year): | 46864.64% |
Latest Opthea Limited News
OPT Breaking Stock News: Dive into OPT Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
High Growth Tech Stocks To Watch In Australia December 2024
GlobeNewswire
22 days ago
Opthea’s Wet AMD Program to be Featured at FLORetina 2024
GlobeNewswire
23 days ago
Opthea to Participate in Citi 2024 Global Healthcare Conference
GlobeNewswire
a month ago
Opthea Appoints Kathy Connell to Board of Directors
Simply Wall St.
a month ago
High Growth Tech Stocks in Australia for November 2024
GlobeNewswire
a month ago
Opthea’s Wet AMD Program Featured at Ophthalmology Events
GlobeNewswire
a month ago
Opthea to Participate in November Investor Conferences
Insider Monkey
2 months ago
Is Opthea Limited (OPT) the Penny Stock with the Biggest Upside Potential According to Analysts?
Compare OPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPT Opthea Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.